Raj, S., Francc, V.I. and Lipshultz, S.E. (2014) Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment. Current Treatment Options in Cardiovascular Medicine, 16, 315.
https://doi.org/10.1007/s11936-014-0315-4

has been cited by the following article:

• TITLE: Effects of Different Doses of Doxorubicin on H9C2 Cells

  AUTHORS: Fan Xu, Xiao Li, Xiaolei Yu, Qingshan Li, Wenxin Li, Xu Xiao

  KEYWORDS: H9C2 Cells, Doxorubicin, Cell Inhibition Rate

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.10 No.3, March 14, 2022

  ABSTRACT: Objective: To study the effect of different doses of doxorubicin on H9C2 cells and to provide a reference for the clinical study of doxorubicin. Methods: Doxorubicin (1, 2, 4, 6, 10 ug/ml) was co-cultured with H9C2 cells for 6, 12 and 24 hours. The morphological changes of cells were observed, and the cell inhibition rates of different time and drug concentration were calculated. Results: Doxorubicin could inhibit the activity of cardiomyocytes in a dose-dependent manner from 1 to 10 ug/ml. Conclusion: A certain dose of doxorubicin has a toxic effect on cardiomyocytes and can cause cardiomyocyte necrosis and apoptosis.